Eisai Initiates Two Phase III Clinical Studies for Fycompa Perampanel in Young Children With PartialOnset Focal Seizures and LennoxGastaut Syndrome

HATFIELD England November 8 2016 PRNewswire FOR UK MEDIA ONLY NOT FOR SWISSAUSTRIAN JOURNALISTS Eisai today announces the initiation of two global multicentre Phase III clinical studie...
Read the full story: Bioportfolio Latest News